Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
IKNA Ikena Oncology
- 1.650
- -0.010-0.60%
Close Dec 13 16:00 ET
79.63MMarket Cap-1.34P/E (TTM)
1.690High1.630Low79.61KVolume1.690Open1.660Pre Close131.48KTurnover0.57%Turnover RatioLossP/E (Static)48.26MShares2.32052wk High0.59P/B22.88MFloat Cap1.22052wk Low--Dividend TTM13.87MShs Float37.610Historical High--Div YieldTTM3.61%Amplitude1.020Historical Low1.651Avg Price1Lot Size
About Ikena Oncology Company
Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.
Company Profile
SymbolIKNA
Company NameIkena Oncology
Listing DateMar 26, 2021
Issue Price16.00
Founded2016
CEODr. Mark Manfredi, PhD
MarketNASDAQ
Employees43
Fiscal Year Ends12-31
Address645 Summer Street,Suite 101
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-273-8343
Websitehttp://www.ikenaoncology.com
Company Executives
- Name
- Position
- Salary
- Dr. Mark Manfredi, PhD
- President, Chief Executive Officer and Director
- 1.24M
- Caroline Germa
- Chief Medical Officer
- --
- Dr. Jeffrey Ecsedy, PhD
- Chief Development Officer
- --
- Dr. Jotin Marango, M.D.,PhD
- Chief Operating Officer, Chief Financial Officer, Head of Corporate Development and Principal Accounting Officer
- 782.32K
- Owen P. Hughes, Jr
- Chairman of the Board
- 167.86K
- Dr. Richard Wooster, PhD
- Independent Director
- 117.86K
- Dr. Maria Koehler, M.D.,PhD
- Independent Director
- 117.86K
- Dr. Iain D. Dukes, D.Phil.
- Independent Director
- 126.97K
- Dr. Otello Stampacchia, PhD
- Independent Director
- 128.25K
- Dr. Jean-Francois Formela,M.D.
- Independent Director
- 130.36K
- Dr. David P. Bonita, M.D.
- Independent Director
- 131.86K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.